Large integrated health systems are facing costly fragmentation as departments independently acquire AI-powered diagnostics, analytics and workflow tools, while research groups build separate integration pipelines. These siloed purchases create duplicate data lakes, inconsistent APIs, interoperability gaps, security and compliance risks, and unclear ownership of models and outcomes. The result: slowed clinical adoption, wasted budget, and increased operational complexity that undermines the potential of AI to improve care.
Enterprise architecture is presented as the strategic remedy: standardized data models, centralized governance, shared integration services and clear procurement guardrails to enable scalable, auditable AI deployments. Effective architecture aligns clinical, IT and research agendas, clarifies responsibilities for model validation and monitoring, and creates reusable infrastructure that lowers marginal costs of new AI tools. Leaders are urged to prioritize architecture investment to unlock AI’s clinical value while managing risk and maximizing return across the enterprise.
